Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own "normal values?"

American Journal of Hematology

Volumn 89, Issue 7, 2014, Pages 671-677

  Vuong, Jennifer ^a   Qiu, Yuelin ^a   La, Myanh ^a   Clarke, Gwen ^a   Swinkels, Dorine W ^b   Cembrowski, George ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; IRON;

ADULT; ARTICLE; BASOPHIL; BLACK PERSON; BLOOD CELL COUNT; CAUCASIAN; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; HEMATOCRIT; HUMAN; IMMUNE SYSTEM; INSULIN RESISTANCE; IRON BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEXICAN AMERICAN; MONOCYTE; NEUTROPHIL COUNT; NORMAL VALUE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; THROMBOCYTE VOLUME; WAIST CIRCUMFERENCE;

ADULT; BLOOD CELL COUNT; BODY MASS INDEX; ERYTHROCYTE COUNT; FEMALE; HEMOGLOBINS; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 84902840540     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23713     Document Type: Article

References (64)

1. Steindel SJ, Rauch WJ, Simon MK, Handsfield J. National Inventory of Clinical Laboratory Testing Services (NICLTS). Development and test distribution for 1996. Arch Pathol Lab Med 2000;124:1201-1208.
2. Friedberg RC, Souers R, Wagar EA, et al. The origin of reference intervals. Arch Pathol Lab Med 2007;31:348-357.
3. Horowitz GL, et al. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, 3rd ed. C28A3E. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
4. Cheng CK, Chan J, Cembrowski GS, van Assendelft OW. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol 2004;10:42-53.
5. Lim EM, Cembrowski G, Cembrowski M, Clarke G. Race-specific white blood cell and neutrophil count reference intervals. Int J Lab Hematol 2010;32(6 Pt 2):590-597.
6. World Health Organization (WHO). Obesity and overweight. Fact Sheet N°311. World Health Organization. Updated March 2013. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed Nov. 8, 2013.
7. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006;331:166-174.
8. Go AS, Mozaffarian D, Roger VL et al. Executive Summary: Heart Disease and Stroke Statistics-2013 update: A report from the American Heart Association. Circulation 2013;127:143-152.
9. Micozzi MS, Albanes D, Stevens RG. Relation of body size and composition to clinical biochemical and hematologic indices in US men and women. Am J Clin Nutr 1989;50:1276-1281.
10. Tungtrongchitr R, Pongpaew P, Phonrat B, et al. Leptin concentration in relation to body mass index (BMI) and hematological measurements in Thai obese and overweight subjects. Southeast Asian J Trop Med Public Health 2000;31:787-794.
11. Al-Hashem FH. Is it necessary to consider obesity when constructing norms for hemoglobin or when screening for anemia using hemoglobin levels? Saudi Med J 2007;41-45.
12. Tatsukawa Y, Hsu WL, Yamada M, et al. White blood cell count, especially neutrophil count, as a predictor of hypertension in a Japanese population. Hypertens Res 2008;1391-1397.
13. Facchini FS, Carantoni M, Jeppesen J, et al. Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 1998;47:831-835.
14. Hanley AJ, Retnakaran R, Qi Y, et al. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab 2009;94:3824-3832.
15. Choi KM, Lee J, Kim YH, et al.Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Diabetes Res Clin Pract 2003;60:205-212.
16. Shim WS, Kim HJ, Kang ES, et al. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 2006;284-291.
17. Kim DJ, Noh JH, Lee BW, et al. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci 2008;193-198.
18. Wang YY, Lin SY, Liu PH, et al. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications 2004;322-327.
19. Grundy SM, James I, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
20. Czernichow S, Kengne AP, Stamatakis E, et al. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev 2011;12:680-687.
21. Carmienke S, Freitag MH, Pischon T, et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. Eur J Clin Nutr 2013;67:573-585.
22. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012;13:275-286.
23. Tuomilehto J, Lindström J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
24. Danaei G, Pan A, Hu FB, Hernán MA. Hypothetical midlife interventions in women and risk of type 2 diabetes. Epidemiology 2013;24:122-128.
25. Cembrowski M, Cembrowski G. NHANES 2000-2003 data used to derive age, sex, and race-stratified hematology reference intervals for Beckman Coulter MAXM. Abstract presented at: The XXth International Symposium on Technical Innovations in Laboratory Hematology; May 8-11, 2007; Miami, FL.
26. Fadini GP, Marcuzzo G, Marescotti MC, et al. Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population. Acta Diabetol 2012;49:445-451.
27. Vallianou NG, Evangelopoulos AA, Panagiotakos DB, et al. Associations of acute-phase reactants with metabolic syndrome in middle-aged overweight or obese people. Med Sci Monit 2010;2:CR56-CR60.
28. Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 2012;249:218-238.
29. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest 2006;116:33-35.
30. Campos SP, Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 1992;12:1789-1797.
31. Chen J, Wildman RP, Hamm LL, et al. Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2960-2965.
32. Mohamed-Ali V, Goodrick S, Rawesh A, et al.Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
33. Jeppesen JL, Maheux P, Facchini FS. White blood cell count and insulin resistance in healthy nonsmoking men. Am Heart J 1994;127:459-461.
34. Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51:455-461.
35. Ishizaka N, Ishizaka Y, Toda E, et al. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Intern Med 2007;1167-1170.
36. Bhargava P, Lee CH. Role and function of macrophages in the metabolic syndrome. Biochem J 2012;442:253-262.
37. Jung CH, Lee WY, Kim BY, et al. The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults. Yonsei Med J 2013;615-620.
38. Fauci AS. Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. Immunology 1975;28:669-680.
39. Yu DT, Clements PJ, Paulus HE, et al. Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest 1974;53:565-571.
40. Boss B, Neeck G, Engelhardt B, Riedel W. Influence of corticosteroids on neutrophils, lymphocytes, their subsets, and T-cell activity markers in patients with active rheumatoid arthritis, compared to healthy controls. Ann N Y Acad Sci 1999;876: 198-200.
41. Grann VR, Ziv E, Joseph CK, et al. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol 2008;143:288-293.
42. Nalls MA, Wilson JG, Patterson NJ, et al. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet 2008;82:81-87.
43. Afenyi-Annan A, Kail M, Combs MR, et al. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion 2008;48:917-924.
44. Arewa O, Cembrowski GS, Arewa OP. The imperative for race-specific neutrophil count reference intervals in white cell count evaluation. J Natl Med Assoc 2011;103:771-772.
45. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023.
46. Barbieri M, Ragno E, Benvenuti E, et al. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 2001;44:1232-1237.
47. Mardi T, Toker S, Melamed S, et al. Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome. Diabetes Res Clin Pract 2005;249-255.
48. Bersch N, Groopman JE, Golde DW. Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro. J Clin Endocrinol Metab 1982;55:1209-1211.
49. Sawada K, Krantz SB, Dessypris EN, et al. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989;83:1701-1709.
50. Ratajczak J, Zhang Q, Pertusini E, et al. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions-Comparison to other cytokines and growth factors. Leukemia 1998;12:371-381.
51. Miyagawa S, Kobayashi M, Konishi N, et al. Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors. Br J Haematol 2000;555-562.
52. Graham JJ, Ryall RG, Wise PH. Glycosylated haemoglobin and relative polycythaemia in diabetes mellitus. Diabetologia 1980;18:205-207.
53. Tsuda K, Nishio I. Leptin and membrane fluidity of erythrocytes in essential hypertension. An electron paramagnetic resonance investigation. Am J Hypertens 2004;17:375-379.
54. Tsuda K. Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men. Obesity (Silver Spring) 2006;14:1505-1510.
55. Di Mascio R, Marchioli R, Vitullo F, Tognoni G. A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3A Investigators. Eur Neurol 1996;36:85-88.
56. Lowe GD, Lee AJ, Rumley A, et al. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997;96:168-173.
57. Fujita B, Strodthoff D, Fritzenwanger M, et al. Altered red blood cell distribution width in overweight adolescents and its association with markers of inflammation. Pediatr Obes 2013;8:385-391.
58. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650-1669.
59. Tussing-Humphreys L, Pusatcioglu C, Nemeth E, Braunschweig C. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. J Acad Nutr Diet 2012;112:391-400.
60. Shah B, Sha D, Xie D, Mohler et al. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004. Diabetes Care 2012;1074-1078.
61. Rose SR, Petersen NJ, Gardner TJ, Hamill RJ, Trautner BW. Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes. J Clin Med Res 2012;4:415-423.
62. Schafer AI. Thrombocytosis. New Engl J Med 2004;350: 1211-1219.
63. Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF Consensus Worldwide Definition of Metabolic Syndrome. International Diabetes Federation. 2006. Available at: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Accessed Nov. 8, 2013.
64. Conrad P, Mackie T, Mehrotra A. Estimating the costs of medicalization. Soc Sci Med 2010;70:1943-1947.